HomeCompareESAIY vs MCD

ESAIY vs MCD: Dividend Comparison 2026

ESAIY yields 3.13% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $54.0K in total portfolio value· pulled ahead in Year 4
10 years
ESAIY
ESAIY
● Live price
3.13%
Share price
$7.66
Annual div
$0.24
5Y div CAGR
0.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$400.49
Full ESAIY calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — ESAIY vs MCD

📍 MCD pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESAIYMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESAIY + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESAIY pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESAIY
Annual income on $10K today (after 15% tax)
$266.34/yr
After 10yr DRIP, annual income (after tax)
$340.42/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $21,953.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESAIY + MCD for your $10,000?

ESAIY: 50%MCD: 50%
100% MCD50/50100% ESAIY
Portfolio after 10yr
$51.6K
Annual income
$13,314.10/yr
Blended yield
25.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

ESAIY
No analyst data
Altman Z
3.0
Piotroski
7/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESAIY buys
0
MCD buys
0
No recent congressional trades found for ESAIY or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESAIYMCD
Forward yield3.13%2.35%
Annual dividend / share$0.24$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.4%42.3%
Portfolio after 10y$24.6K$78.5K
Annual income after 10y$400.49$26,227.70
Total dividends collected$3.6K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ESAIY vs MCD ($10,000, DRIP)

YearESAIY PortfolioESAIY Income/yrMCD PortfolioMCD Income/yrGap
1$11,015$314.60$10,815$334.85+$200.00ESAIY
2$12,111$325.14$11,826$491.71+$285.00ESAIY
3$13,294$335.45$13,123$730.06+$171.00ESAIY
4← crossover$14,570$345.51$14,853$1,100.07$283.00MCD
5$15,945$355.31$17,257$1,690.61$1.3KMCD
6$17,426$364.87$20,752$2,667.01$3.3KMCD
7$19,020$374.16$26,103$4,354.83$7.1KMCD
8$20,735$383.19$34,794$7,437.78$14.1KMCD
9$22,578$391.97$49,926$13,461.60$27.3KMCD
10$24,559$400.49$78,550$26,227.70$54.0KMCD

ESAIY vs MCD: Complete Analysis 2026

ESAIYStock

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESAIY Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this ESAIY vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESAIY vs SCHDESAIY vs JEPIESAIY vs OESAIY vs KOESAIY vs MAINESAIY vs YUMESAIY vs QSRESAIY vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.